Edition:
United States

Verona Pharma PLC (VRNA.OQ)

VRNA.OQ on NASDAQ Stock Exchange Global Market

6.49USD
23 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.49
Open
$6.34
Day's High
$6.49
Day's Low
$6.24
Volume
4,210
Avg. Vol
1,718
52-wk High
$25.01
52-wk Low
$5.93

Chart for

About

Verona Pharma plc is a United Kingdom-based clinical-stage biopharmaceutical company. The principal activity of the Company is the development of drugs for the treatment of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma and cystic fibrosis. The Company's product candidate, RPL554, is a... (more)

Overall

Beta: -0.55
Market Cap(Mil.): £111.12
Shares Outstanding(Mil.): 105.33
Dividend: --
Yield (%): --

Financials

  VRNA.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -0.22 -- --
ROI: -30.48 0.60 13.80
ROE: -30.87 -2.18 15.29

Earnings vs. Estimates